In a study conducted at the Ovarian Cancer Research Foundation (OCRF) at Monash
Medical Centre in Melbourne, an antibody detection method developed by Biosceptre
successfully identified 100% of the invasive ovarian carcinomas (malignant cancers of
the ovaries) included in the tissue analysis.